Paclitaxel plus cisplatin increases survival, costs in ovarian cancer

By  

Inpharma, Vol. 1, Iss. 1345, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Paclitaxel plus cisplatin and lonidamine showed `good activity' in advanced ovarian cancer

By  

Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study

By Chen Kai   Chen Wan   Chen Xia   Jia Yi   Peng Gui   Chen Li  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 39, Iss. 1, 2014-03 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite

Paclitaxel vs cyclophosphamide, + cisplatin, for ovarian cancer

By  

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Cisplatin plus paclitaxel superior in cervical cancer?

By  

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite